Next Financial Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$301K Sell
8,798
-3,699
-30% -$145K 0.02% 731
2021
Q3
$603K Sell
12,497
-636
-5% -$29.4K 0.05% 394
2021
Q2
$593K Buy
13,133
+206
+2% +$9.13K 0.05% 399
2021
Q1
$624K Buy
12,927
+1,322
+11% +$68.8K 0.06% 353
2020
Q4
$624K Buy
11,605
+640
+6% +$28.9K 0.06% 310
2020
Q3
$405K Sell
10,965
-9
-0.1% -$335 0.04% 395
2020
Q2
$340K Buy
10,974
+800
+8% +$22.2K 0.04% 380
2020
Q1
$281K Buy
10,174
+7,524
+284% +$225K 0.04% 442
2019
Q4
$78K Buy
2,650
+200
+8% +$4.76K 0.01% 1046
2019
Q3
$47K Sell
2,450
-250
-9% -$5.86K 0.01% 1165
2019
Q2
$59K Buy
2,700
+1,800
+200% +$39.5K 0.01% 1115
2019
Q1
$18K Buy
+900
New +$15.6K ﹤0.01% 988
2016
Q4
Sell
-300
Closed -$2K 2446
2016
Q3
$2K Hold
300
﹤0.01% 2168
2016
Q2
$2K Hold
300
﹤0.01% 1597
2016
Q1
$2K Buy
+300
New +$1.97K ﹤0.01% 1553

Other funds holding NEO

Next Financial Group's NEO Position: Q4 2021 in Review

Next Financial Group reduced its NeoGenomics (NEO) stake by 30% in Q4 2021, selling an estimated $145K and leaving 8,798 shares worth $301K. The position accounts for 0.02% of the portfolio, ranked #731.

Next Financial Group first reported a position in NEO in Q1 2016 and has held it in 15 quarters since. The position peaked at $624K in Q1 2021. 309 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Next Financial Group held 8,798 shares of NeoGenomics worth $301K as of Q4 2021.
  • Next Financial Group sold 3,699 NeoGenomics shares in Q4 2021, an estimated $145K.
  • NeoGenomics made up 0.02% of Next Financial Group's portfolio in Q4 2021, its #731 holding.
  • Next Financial Group first reported a position in NeoGenomics in Q1 2016 and has held it in 15 quarters since.
  • Next Financial Group's NeoGenomics position peaked at $624K in Q1 2021.
  • 309 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.